New Delhi, April 9 Glenmark Pharmaceuticals announced on Thursday that it has received final approval from the US health regulator for its generic version of progesterone vaginal inserts used in fertility treatments.The approval from the US Food and Drug Administration (USFDA) is for 100 mg...
bioequivalence
drug approval
endometrin
fertility treatments
generic pharmaceuticalsglenmarkpharmaceuticals
medical devices
north america
pharmaceutical sales
progesterone vaginal inserts
therapeutic equivalence
us food and drug administration (usfda)
us market
vaginal inserts
women's healthcare
New Delhi, March 21 Indian pharmaceutical companies Sun Pharma, Dr Reddy's, and Glenmark announced on Saturday the launch of their generic versions of semaglutide injection, used for diabetes and weight management, following the expiration of patents on products like Ozempic and Wegovy in India...
New Delhi, February 27 Glenmark Pharmaceuticals announced on Friday that its US-based unit is preparing to introduce a generic sodium phosphate injection in the American market.The Mumbai-based pharmaceutical company stated that its product is therapeutically equivalent to Hosira Inc.'s...
New Delhi, February 27 Glenmark Pharmaceuticals announced on Friday that its US-based unit is preparing to introduce a generic sodium phosphate injection in the American market.The Mumbai-based pharmaceutical company stated that its product is therapeutically equivalent to Hosira Inc.'s...
bse stock exchange
drug sales
generic drug
glenmarkpharmaceuticals
india
injection
iqvia sales data
pharmaceutical distribution
pharmaceutical industry
pharmaceutical market
pharmaceutical products
regulatory filing
sodium phosphate injection
united states
us market